In the healthcare industry AI shows a lot of promise but there's a lot at stake if any mistakes are made. Medicine is considered to be the area that AI is most likely to benefit in the future and as right now its implementation is split into two categories: virtual assistance and physical assistance. Proponents of AI in healthcare believe it would reduce costs and lead to better outcomes by using the large heaps of medical information at its disposal.
This form of assistance mostly deals with health records and it utilizes machine learning capabilities of AI to more effectively diagnose and treat patients. One study aiming to prove how efficient this was, used AI to determine different patients' risk of death when they entered the hospital with a high rate of success.
A breakthrough that has recently been made has to do with AI and its use of detecting breast cancer. This new deep-learning model created by MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) and Massachusetts General Hospital (MGH) is able to predict how likely a patient is in developing breast cancer as much as 5 years in the future based on their mammogram. The model was able to learn subtle patterns in the breast tissue that indicates malignant tumors (Conner-Simons 2019). The model takes information from approximately 90,000 mammograms so that it can detect patterns that the human eye is unable to detect. Before this model was created the ways used to predict the risk of breast cancer was determined through age, family history, and breast density (Conner-Simons 2019).
Another aspect of AI that has recently been developed for the medical field is robotic surgical devices. These surgeries are considered to be minimally invasive and involve technology that helps the surgeon to do tasks that they would otherwise have a hard time doing without large incisions. This process of cognitive surgical robotics intertwines the information gained from actual surgeries to improve techniques in order to better enhance the physician's instrument precision and effectively reduce the time needed for the patient to stay for recovery in the hospital. Certain robotic surgical devices allow the surgeon to operate a robotic arm to better facilitate the performance of laparoscopic surgeries, a specialized technique of performing minimally invasive surgery, which correlates with a shorter stay in the hospital (Barbash 2010). These medical techniques benefit in saving billions of dollars for the U.S healthcare economy while it may lead to higher costs for the patient (Barbash 2010).
This field includes robots and nanorobots assisting doctors during surgery and patients during their treatment and recovery. Nanorobots are about the size of a nanometer and is a relatively new technology that might be able to kill cancer cells and improve vaccines.
It’s no doubt that Artificial Intelligence has several applications across the realm of medicine. Most people and medical patients would agree that AI could revolutionize the way we treat patients with a variety of ailments. However, it wasn’t until 2020 that it was found how little trust current medical patients had in the use of AI in treating themselves. An anonymous questionnaire issued by the Journal of Medical Internet Research to patients receiving either computed tomography, or magnetic resonance imaging revealed that 96.2% of patients preferred the physician’s opinion over what the AI computed (Lennartz, 2020). This reflects the general unwillingness of the human race to do what they believe is surrender judgement to a robot. However, AI is becoming increasingly more accepted in the medical community. In the same study, patients were more inclined to trust a statement computed by AI if the system was under physician supervision. This study is essential in figuring out how to go about the use of AI in medical situations. The JMIR concluded that the “application of AI in medicine should be disclosed and controlled to protect patient interests and meet ethical standards.”
The rise of COVID-19 has resulted in a drastic increase of the use of Artificial Intelligence across the board. Most obviously, quarantine periods all over the world increased the use of digital technology. People were sent home from work, and forced to adapt to a totally new format using Zoom and other applications in order to communicate with coworkers. While Zoom Video Communications and other technology-based companies “zoomed,” other companies suffered immensely. This called for innovation, and in these short months, the economy was radically revamped through the use of AI (see Economy tab).
This sudden pandemic also encouraged scientists and developers to start using AI for the greater good. Their innovations were implemented to improve both COVID testing, and in the search of a capable treatment.
Although not widespread, (Chen et al., 2019) has released an article discussing artificially intelligent biosensors that are being developed as “point-of-care testing for infectious diseases.” The system scans for biomarkers such as antibodies, aptamer, and the pathogen itself, and then reports its findings. According to the study, this AI can identify infection in real time, making it extremely effective as a medical treatment, and contributing to epidemic outbreak prevention. This is an especially timely breakthrough, considering our country’s newly exposed weakness to pandemics. One of the major issues of early COVID-19 was deciding treatments for specific individuals. Would a ventilator increase chances of survival, or worsen the condition of the patient? That issue is precisely what is addressed by this use of POC testing, and the perfect example of how A.I. can be used successfully in a variety of ways, including for the purpose of medicine.
In China, scientists took a different approach in studying the potential of medical A.I. to discover treatments. When the outbreak began in Wuhan, China in 2019, the use of Traditional Chinese Medicine (TCM) as a treatment for the virus was gaining popularity. Some experts strongly opposed the use of it, while others swore by its legitimacy. Chinese scientist Zeheng Wang published an article in the Journal of Ethnopharmacology, in which a study was conducted to evaluate the merit of TCM using Artificial Neural Network (ANN), an artificially intelligent deep learning system. The use of this system was found to have great success as ANN is becoming increasingly effective in describing relationships between data that it identifies (Zhang et al., 2020). In addition, this technology has already developed a suitable approach towards high-accuracy TCM prediction (Yao et al., 2019). Not only does this reveal the merit to treating COVID-19 using traditional medicine, scientists also state, “Utilizing deep learning (human like evaluation), recent research have also predicted possible modern antiviral drugs for COVID-19 (Beck et al., 2020).” Ultimately, they concluded that some TCM were safe to be approved for the treatment of COVID-19, while others were not considered good treatments, or were associated with unwanted side effects.
These uses of A.I. mainly express that its use is always in question; both for good and bad. A.I. can be utilized when addressing basically anything. And, in a time where a pandemic is ravaging through the planet alongside countless other health emergencies, A.I. might be our vehicle to a solution.
The first A.I. based TCM clinic opens in China, November of 2017
Photo by 浙江在线新闻网站 版权所有 licensed under Creative Commons. http://chinaplus.cri.cn/news/china/9/20171126/56700.html
Lennartz, Simon. “PMC - NCBI.” National Center for Biotechnology Information, U.S. National Library of Medicine, www.ncbi.nlm.nih.gov/pmc/?cmd=Search.
Jain, Shikha, et al. “Internet of Medical Things (IoMT)-Integrated Biosensors for Point-of-Care Testing of Infectious Diseases.” Biosensors and Bioelectronics, Elsevier, 6 Feb. 2021, www.sciencedirect.com/science/article/pii/S0956566321001111.
Ahrens, H. D., and R. R. Galiev. “Viability of Farm Households in Russia: Theoretical Approaches and Practical Conclusions.” Studies on Russian Economic Development, Pleiades Publishing, 31 May 2019, link.springer.com/article/10.1134%2FS1075700719030043.
Wang, Zeheng, et al. “Evaluating the Traditional Chinese Medicine (TCM) Officially Recommended in China for COVID-19 Using Ontology-Based Side-Effect Prediction Framework (OSPF) and Deep Learning.” Journal of Ethnopharmacology, Elsevier, 22 Feb. 2021, www.sciencedirect.com/science/article/pii/S0378874121001835.
“China's First AI-Based TCM Clinic Opens in Wuzhen.” China Plus, chinaplus.cri.cn/news/china/9/20171126/56700.html.